Class Action

SeroVital-hgh Supplements

Class Action

SeroVital-hgh Supplements

In May 2018, a class-action lawsuit was filed against SanMedica International for allegedly falsely advertising the Human Growth Hormone (HGH) supplement SeroVital-hgh. Specifically, plaintiffs claim that SanMedica falsely markets the supplement as able to increase HGH levels by 682% when, according to the complaint, it does increase HGH levels at all. In addition, the complaint alleges that the supplement reduces wrinkles, decreases body fat, increases lean muscle mass, makes stronger bones, improves mood, and heightens sex drive when, according to plaintiffs, the product does not provide any of these benefits. (Pizana et al v. SanMedica International, LLC, Case No. 18-cv-644, E.D. Cal.)

For more of TINA.org’s coverage of SeroVital-hgh, click here.


Class-Action Tracker

SeroVital

Class Action

SeroVital

April 2017: The Ninth Circuit Court of Appeals affirmed the district court’s decision to dismiss this lawsuit. March 2015: The plaintiffs appealed the district court’s decision to dismiss the lawsuit.…

Sanmedica’s Sero Vital-hgh

Class Action

Sanmedica’s Sero Vital-hgh

In Oct 2016, a class-action lawsuit was filed against Sanmedica International for allegedly falsely advertising that Sero Vital-hgh provides anti-aging benefits. Specifically, the complaint alleges that the company markets the…


The Latest

Filters

Bumbu Rum

Ad Alert

Bumbu Rum

Lawsuit alleges beverage doesn’t meet federal standards to be marketed as rum.

Lomi

Ad Alert

Lomi

TINA.org digs into company’s broad composting claims.


Show More